MRI and 11C-methyl-L-methionine PET Differentiate Bevacizumab True Responders After Initiating Therapy for Recurrent Glioblastoma.
Autor: | Takaaki Beppu, Kazunori Terasaki, Toshiaki Sasaki, Yuichi Sato, Makiko Tomabechi, Kenichi Kato, Makoto Sasaki, Kuniaki Ogasawara |
---|---|
Zdroj: | Clinical Nuclear Medicine; Nov2016, Vol. 41 Issue 11, p852-857, 6p, 1 Color Photograph, 3 Graphs |
Databáze: | Complementary Index |
Externí odkaz: |